| Radical cystectomy against intravesical BCG for high-risk high-grade nonmuscle invasive bladder cancer: results from the randomized controlled BRAVO-feasibility study JWF Catto, K Gordon, M Collinson, H Poad, M Twiddy, M Johnson, S Jain, ... Journal of Clinical Oncology 39 (3), 202-214, 2021 | 71 | 2021 |
| Non-visible haematuria for the detection of bladder, upper tract, and kidney cancer: an updated systematic review and meta-analysis I Jubber, SF Shariat, S Conroy, WS Tan, PC Gordon, Y Lotan, ... European urology 77 (5), 583-598, 2020 | 53 | 2020 |
| Unrestricted faecal calprotectin testing performs poorly in the diagnosis of inflammatory bowel disease in patients in primary care S Conroy, MF Hale, SS Cross, K Swallow, RH Sidhu, R Sargur, AJ Lobo Journal of clinical pathology 71 (4), 316-322, 2018 | 43 | 2018 |
| Impact of COVID‐19 on the management and outcomes of ureteric stones in the UK: a multicentre retrospective study MHV Byrne, F Georgiades, A Light, CE Lovegrove, C Dominic, J Rahman, ... BJU international 131 (1), 82-89, 2023 | 10 | 2023 |
| Genome-wide meta-analysis identifies novel genes associated with recurrence and progression in non–muscle-invasive bladder cancer TE Galesloot, AJ Grotenhuis, D Kolev, KK Aben, RT Bryan, JWF Catto, ... European Urology Oncology 5 (1), 70-83, 2022 | 10 | 2022 |
| Comparing open-radical cystectomy and robot-assisted radical cystectomy: current status and analysis of the evidence P Khetrapal, S Conroy, JD Kelly, JWF Catto Current Opinion in Urology 30 (3), 400-406, 2020 | 10 | 2020 |
| Precision oncology using ex vivo technology: a step towards individualised cancer care? ST Williams, G Wells, S Conroy, H Gagg, R Allen, O Rominiyi, T Helleday, ... Expert Reviews in Molecular Medicine 24, e39, 2022 | 8 | 2022 |
| Mapping european association of urology guideline practice across europe: an audit of androgen deprivation therapy use before prostate cancer surgery in 6598 cases in 187 … S MacLennan, N Azevedo, E Duncan, J Dunsmore, L Fullwood, N Lumen, ... European Urology 83 (5), 393-401, 2023 | 6 | 2023 |
| Hyperthermic intravesical chemotherapy with mitomycin‐C for the treatment of high‐risk non‐muscle‐invasive bladder cancer patients S Conroy, K Pang, I Jubber, SA Hussain, DJ Rosario, MG Cumberbatch, ... BJUI compass 4 (3), 314-321, 2023 | 5 | 2023 |
| Undergraduate Urology Education: A Fundamental Pillar in Building the Next Generation of Urologists. S Conroy European Urology 78 (3), 385-386, 2020 | 3 | 2020 |
| Ex-vivo drug screening of surgically resected glioma stem cells to replace murine avatars and provide personalise cancer therapy for glioblastoma patients H Gagg, ST Williams, S Conroy, KN Myers, C McGarrity-Cottrell, C Jones, ... F1000Research 12, 2023 | 2 | 2023 |
| Implementing frailty assessment and management in oncology services A Cree, J Pearce, NML Battisti, M Baxter, J Brown, S Conroy, F Gomes, ... Royal College of Physicians and Royal College of Radiologists, 2023 | 1 | 2023 |
| Diagnosis, treatment, and survival from kidney cancer: real‐world National Health Service England data between 2013 and 2019 S Conroy, JWF Catto, A Bex, JE Brown, J Cartledge, A Fielding, RJ Jones, ... BJU international 132 (5), 541-553, 2023 | | 2023 |
| Acute haemorrhage from a large renal epithelioid angiomyolipoma: diagnostic and management considerations in a teenage patient with a rare cancer S Conroy, J Griffin, M Cumberbatch, S Pathak BMJ Case Reports CP 16 (5), e252351, 2023 | | 2023 |
| Ex-vivo high-throughput drug screening in bladder cancer: an opportunity to increase treatment personalisation, improve patient selection, and expedite novel drug discovery. S Conroy University of Sheffield, 2023 | | 2023 |
| 11 Non-muscle-invasive bladder cancer S Conroy Challenging Cases in Urological Surgery, 107, 2022 | | 2022 |
| Compound to Clinic? A Preclinical High-throughput Screening Pathway To Expedite Drug Discovery in Bladder Cancer S Conroy, AHT Nguyen European urology 82 (3), 271-272, 2022 | | 2022 |
| Case of the month from the University of Sheffield, UK: Expediting definitive treatment in patients with invasive bladder cancer: an MRI‐guided pathway S Conroy, R Hubbard, AP Noon, SA Hussain, J Griffin, S Kennish, ... Bju International 129 (6), 691, 2022 | | 2022 |
| Ex vivo-led drug discovery in glioblastoma H Gagg, S Williams, R Allen, S Conroy, O Rominiyi, G Wells, J Rantala, ... Brain Tumor Research and Treatment 10 (Suppl), 2022 | | 2022 |
| Non-visiblehaematuriafor theDetectionofBladder, UpperTract, and Kidney Cancer: An Updated Systematic Review and Meta-analysis I Jubber, SF Shariat, S Conroy, WS Tan, PC Gordon, Y Lotan, ... | | 2019 |
